The first NHS online maternity guide, offering a wealth of information on pregnancy and birth, at just the click of a mouse, was launched today. The new Pregnancy Care Planner gives the latest and most comprehensive advice on all aspects of pregnancy, from getting pregnant, early pregnancy, the scans, to the birth, and the most up to date comparative guides to what is on offer at local maternity units.

The mission of EPILEPSIAE Project is to use Information and Communication Technologies to empower the epileptic patients to monitor their own risks and improve their safety in daily life, strengthening their social integration.

The preDiCT project officially launched 1 June 2008, with a mission to model, simulate, and ultimately predict the impact of pharmacological compounds on the heart's rhythm using computer models. This will require advances beyond the current state-of-the-art in:

The CARS Explorer project, coordinated by Didier Marguet from the French National Institute for Health and Medical Research (Inserm Unit 631, CIML, Marseille), was officially launched in April in Marseille, France. CARS Explorer is a collaborative research project funded by the European Commission under the Health priority of the 7th Framework Programme.

VTT Technical Research Centre of Finland, GE Healthcare, a division of the General Electric Company (NYSE: GE) and a Consortium of leading research institutions across Europe announced the PredictAD project, a research collaboration aimed at developing new diagnostic procedures for patients with Alzheimer's disease.

Researchers define cell therapy as the transplantation of living cells for the replacement or repair of damaged tissue and/or cells. Hot on the heels of stem cell therapy research is a group of leading cell imaging experts who are participating in ENCITE (European network for cell imaging and tracking expertise), a four-year project supported by the EU with €11 million in funding.

NHS Connecting for Health, the flagship NHS IT programme, is to be evaluated by a national team of researchers led by the University of Edinburgh. The £1.5m study, which begins on 1st September 2008, will run until December 2010 and also involves researchers from the Universities of Nottingham, LSE, School of Pharmacy and the NHS.